Cardiologs

Since 2014, Cardiologs provides a cloud-based solution powered by a medical-grade AI trained over 1.5m ECG cases, which already automates 80% of the labor required to perform an expert-level diagnostic. Thousands of patients are diagnosed around the world every month thanks to Cardiologs. Cardiologs is the world’s first medical device powered by deep learning, to have received regulatory clearance (CE Mark in August 2016). It is also among the first to have received FDA clearance (June 2017). Cardiologs is commercialized in the US and plans to accelerate growth in the EU in 2020.